PPB - Services

Complaints, Feedback and Enquiry

MANDATED RECALL OF TAMEDOL ORAL SOLUTION (PARACETAMOL ORAL SOLUTION, 120 MG/5 ML, 60 MLS) MANUFACTURED BY BIOPHARMA LTD, KENYA

[featured_image]
  • Version
  • Download 297
  • File Size 1.48 MB
  • File Count 1
  • Create Date September 22, 2023
  • Last Updated September 22, 2023

MANDATED RECALL OF TAMEDOL ORAL SOLUTION (PARACETAMOL ORAL SOLUTION, 120 MG/5 ML, 60 MLS) MANUFACTURED BY BIOPHARMA LTD, KENYA

The Pharmacy and Poisons Board (PPB) has received multiple market complaints on the quality of several batches of Tamedol oral solution (Paracetamol oral solution, 120mg/5ml, 60 mls) manufactured by Biopharma LTD, Kenya. In response to these concerns, the P B upon investigations, indeed confirmed that the product FAILED to meet the prescribed market authorization requirements and has initiated mandatory recall of the product by the manufacturer in line with Section 3A(i) of the Pharmacy and Poisons Act (Cap. 244).

Attached Files

FileAction
MANDATED_RECALL_TAMED0L_Signed Copy.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published. Required fields are marked *